AZTA
Price
$26.05
Change
+$0.69 (+2.72%)
Updated
Jul 13 closing price
Capitalization
1.2B
28 days until earnings call
Intraday BUY SELL Signals
CUPR
Price
$4.33
Change
-$0.64 (-12.88%)
Updated
Jul 13 closing price
Capitalization
11.61M
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs CUPR

AZTA vs CUPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AZTA vs. CUPR commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and CUPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (AZTA: $26.05 vs. CUPR: $4.33)
Brand notoriety: AZTA and CUPR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 36% vs. CUPR: 0%
Market capitalization -- AZTA: $1.2B vs. CUPR: $11.61M
AZTA [@Pharmaceuticals: Other] is valued at $1.2B. CUPR’s [@Pharmaceuticals: Other] market capitalization is $11.61M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileCUPR’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • CUPR’s FA Score: 0 green, 5 red.
According to our system of comparison, CUPR is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while CUPR’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 4 bearish.
  • CUPR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than CUPR.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +1.48% price change this week, while CUPR (@Pharmaceuticals: Other) price change was -23.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

Reported Earning Dates

AZTA is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.2B) has a higher market cap than CUPR($11.6M). CUPR YTD gains are higher at: 35.279 vs. AZTA (-21.678). AZTA has higher annual earnings (EBITDA): 36.6M vs. CUPR (-4.56M). AZTA has higher revenues than CUPR: AZTA (596M) vs CUPR (49.9K).
AZTACUPRAZTA / CUPR
Capitalization1.2B11.6M10,353%
EBITDA36.6M-4.56M-803%
Gain YTD-21.67835.279-61%
P/E Ratio42.43N/A-
Revenue596M49.9K1,194,389%
Total Cash381MN/A-
Total Debt55.7MN/A-
FUNDAMENTALS RATINGS
AZTA: Fundamental Ratings
AZTA
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTACUPR
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
70%
Bullish Trend 20 days ago
90%
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signal:
Gain/Loss:
CUPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APUS0.740.02
+2.36%
Apimeds Pharmaceuticals US Inc.
TBPH16.90-0.03
-0.18%
Theravance Biopharma
TORO4.91-0.03
-0.61%
Toro Corp
BBDO3.15-0.04
-1.25%
Banco Bradesco SA
BMI140.12-4.06
-2.82%
Badger Meter

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.72%
IQV - AZTA
60%
Loosely correlated
-0.14%
RVTY - AZTA
59%
Loosely correlated
-1.05%
A - AZTA
59%
Loosely correlated
-0.19%
MTD - AZTA
59%
Loosely correlated
+0.26%
BRKR - AZTA
58%
Loosely correlated
-1.81%
More

CUPR and

Correlation & Price change

A.I.dvisor tells us that CUPR and LUCY have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CUPR and LUCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUPR
1D Price
Change %
CUPR100%
-12.88%
LUCY - CUPR
10%
Poorly correlated
-2.78%
RGEN - CUPR
8%
Poorly correlated
+0.44%
KMTS - CUPR
4%
Poorly correlated
-4.73%
NNNN - CUPR
4%
Poorly correlated
+6.18%
AZTA - CUPR
3%
Poorly correlated
+2.72%
More